EFTR – effector therapeutics, inc. (US:NASDAQ)
Stock Stats
News
eFFECTOR Therapeutics to Participate in Upcoming Investor Conference [Yahoo! Finance]
eFFECTOR Therapeutics to Participate in Upcoming Investor Conference
eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
eFFECTOR Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Form ARS eFFECTOR Therapeutics, For: Dec 31
Form DEFA14A eFFECTOR Therapeutics,
Form DEF 14A eFFECTOR Therapeutics, For: Jun 13
Form PRE 14A eFFECTOR Therapeutics, For: Jun 13
Form EFFECT eFFECTOR Therapeutics,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.